Viewing StudyNCT01587703



Ignite Creation Date: 2024-05-06 @ 12:28 AM
Last Modification Date: 2024-10-26 @ 10:50 AM
Study NCT ID: NCT01587703
Status: COMPLETED
Last Update Posted: 2020-03-16
First Post: 2012-04-03

Brief Title: A Study to Investigate the Safety Pharmacokinetics Pharmacodynamics and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma NMC and Other Cancers
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Carcinoma Midline
Keywords:
Name View
Oncology View
BRD3 View
GSK525762 View
NUT Midline Carcinoma View
MYCN-amplified Solid Tumor View
BRD4 View
BET inhibitor View
bromodomains View
NMC View
Colorectal C ancer View
Small Cell Lung Cancer View
Multiple Myeloma View
Neuroblastoma View